37426819|t|Pharmacological interventions for preventing opioid-induced hyperalgesia in adults after opioid-based anesthesia: a systematic review and network meta-analysis.
37426819|a|Background: Opioid-induced hyperalgesia (OIH) is an adverse event of prolonged opioid use that increases pain intensity. The optimal drug to prevent these adverse effects is still unknown. We aimed to conduct a network meta-analysis to compare different pharmacological interventions for preventing the increase in postoperative pain intensity caused by OIH. Methods: Several databases were searched independently for randomized controlled trials (RCTs) comparing various pharmacological interventions to prevent OIH. The primary outcomes were postoperative pain intensity at rest after 24 h and the incidence of postoperative nausea and vomiting (PONV). Secondary outcomes included pain threshold at 24 h after surgery, total morphine consumption over 24 h, time to first postoperative analgesic requirement, and shivering incidence. Results: In total, 33 RCTs with 1711 patients were identified. In terms of postoperative pain intensity, amantadine, magnesium sulphate, pregabalin, dexmedetomidine, ibuprofen, flurbiprofen plus dexmedetomidine, parecoxib, parecoxib plus dexmedetomidine, and S (+)-ketamine plus methadone were all associated with milder pain intensity than placebo, with amantadine being the most effective (SUCRA values = 96.2). Regarding PONV incidence, intervention with dexmedetomidine or flurbiprofen plus dexmedetomidine resulted in a lower incidence than placebo, with dexmedetomidine showing the best result (SUCRA values = 90.3). Conclusion: Amantadine was identified as the best in controlling postoperative pain intensity and non-inferior to placebo in the incidence of PONV. Dexmedetomidine was the only intervention that outperformed placebo in all indicators. Clinical Trial Registration: https://www.crd.york.ac. uk/prospero/display_record.php?, CRD42021225361.
37426819	60	72	hyperalgesia	Disease	MESH:D006930
37426819	188	200	hyperalgesia	Disease	MESH:D006930
37426819	202	205	OIH	Disease	MESH:D006930
37426819	266	270	pain	Disease	MESH:D010146
37426819	476	494	postoperative pain	Disease	MESH:D010149
37426819	515	518	OIH	Disease	MESH:D006930
37426819	674	677	OIH	Disease	MESH:D006930
37426819	705	723	postoperative pain	Disease	MESH:D010149
37426819	774	807	postoperative nausea and vomiting	Disease	MESH:D020250
37426819	809	813	PONV	Disease	MESH:D020250
37426819	844	848	pain	Disease	MESH:D010146
37426819	888	896	morphine	Chemical	MESH:D009020
37426819	1071	1089	postoperative pain	Disease	MESH:D010149
37426819	1101	1111	amantadine	Chemical	MESH:D000547
37426819	1113	1131	magnesium sulphate	Chemical	MESH:D008278
37426819	1133	1143	pregabalin	Chemical	MESH:D000069583
37426819	1145	1160	dexmedetomidine	Chemical	MESH:D020927
37426819	1162	1171	ibuprofen	Chemical	MESH:D007052
37426819	1173	1185	flurbiprofen	Chemical	MESH:D005480
37426819	1191	1206	dexmedetomidine	Chemical	MESH:D020927
37426819	1208	1217	parecoxib	Chemical	MESH:C409945
37426819	1219	1228	parecoxib	Chemical	MESH:C409945
37426819	1234	1249	dexmedetomidine	Chemical	MESH:D020927
37426819	1255	1269	S (+)-ketamine	Chemical	MESH:C000629870
37426819	1275	1284	methadone	Chemical	MESH:D008691
37426819	1317	1321	pain	Disease	MESH:D010146
37426819	1351	1361	amantadine	Chemical	MESH:D000547
37426819	1420	1424	PONV	Disease	MESH:D020250
37426819	1454	1469	dexmedetomidine	Chemical	MESH:D020927
37426819	1473	1485	flurbiprofen	Chemical	MESH:D005480
37426819	1491	1506	dexmedetomidine	Chemical	MESH:D020927
37426819	1556	1571	dexmedetomidine	Chemical	MESH:D020927
37426819	1631	1641	Amantadine	Chemical	MESH:D000547
37426819	1684	1702	postoperative pain	Disease	MESH:D010149
37426819	1761	1765	PONV	Disease	MESH:D020250
37426819	1767	1782	Dexmedetomidine	Chemical	MESH:D020927
37426819	Cotreatment	MESH:D005480	MESH:D020927
37426819	Negative_Correlation	MESH:C000629870	MESH:D010146
37426819	Negative_Correlation	MESH:D020927	MESH:D010149
37426819	Cotreatment	MESH:C000629870	MESH:D008691
37426819	Negative_Correlation	MESH:D005480	MESH:D010146
37426819	Negative_Correlation	MESH:D020927	MESH:D020250
37426819	Negative_Correlation	MESH:D008691	MESH:D010149
37426819	Negative_Correlation	MESH:D000547	MESH:D010149
37426819	Cotreatment	MESH:C409945	MESH:D020927
37426819	Positive_Correlation	MESH:D000547	MESH:D020250
37426819	Negative_Correlation	MESH:D007052	MESH:D010146
37426819	Negative_Correlation	MESH:D000069583	MESH:D010146
37426819	Negative_Correlation	MESH:D020927	MESH:D010146
37426819	Negative_Correlation	MESH:D007052	MESH:D010149
37426819	Negative_Correlation	MESH:D000547	MESH:D010146
37426819	Negative_Correlation	MESH:C409945	MESH:D010149
37426819	Negative_Correlation	MESH:D005480	MESH:D010149
37426819	Negative_Correlation	MESH:C000629870	MESH:D010149
37426819	Negative_Correlation	MESH:D008278	MESH:D010146
37426819	Negative_Correlation	MESH:C409945	MESH:D010146
37426819	Negative_Correlation	MESH:D000069583	MESH:D010149
37426819	Negative_Correlation	MESH:D008691	MESH:D010146

